- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02800876
Evaluation of Aortic Aneurysms With Focus on Wall Stress and Wall Rupture Risk
June 10, 2016 updated by: Thi Dan Linh Nguyen-Kim, University of Zurich
Evaluation of Aortic Aneurysms With Focus on Wall Stress and Wall Rupture Risk by Computational Finite Element Analysis With Dedicated Software
Retrospective study to evaluate the impact of computational wall stress analysis based on computed tomography (CT) of ruptured and not-ruptured aortic aneurysms as an additional predictor for rupture with dedicated software.
Study Overview
Detailed Description
In patients with known aortic aneurysm who received clinically indicated CT during a time period from 01/2004-12/2013 the CT data was evaluated with dedicated software, A4clinics, VASCOPS GmbH, Graz, Austria.
The following parameters will be evaluated: exterior and luminal diameter, intraluminal thrombus (ILT) thickness, vessel-, luminal- and intraluminal thrombus volume, peak wall stress (PWS), peak wall rupture risk (PWRR), von Mises-stress and rupture risk-index in the ILT.
Study Type
Observational
Enrollment (Anticipated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zurich, Switzerland, 8091
- Recruiting
- University Hospital Zurich
-
Contact:
- Thi Dan Linh Nguyen-Kim, Dr. med.
- Phone Number: 0041442552900
- Email: thidanlinh.nguyen@usz.ch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with known aortic aneurysms, who underwent clinical indicated CT during a time period from 01/2004-12/2013
Description
Inclusion Criteria:
Clinical indicated CT data from patients with known aortic aneurysms.
Clinical indication was:
- Follow up CT examination by known aortic aneurysm
- Patient with known aortic aneurysm with new acute clinical symptoms
- Patients with clinical suspicion of aortic aneurysm
Exclusion Criteria:
- known exclusion criteria for CT examination as known allergy to iodine or contrast media
- known pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
asymptomatic not ruptured aneurysm
Patients with asymptomatic not ruptured aortic aneurysms greater than 3 cm who received a clinical indicated CT
|
|
|
symptomatic not ruptured aneurysm
Patients with symptomatic aortic aneurysms greater than 3 cm who received a clinical indicated CT
|
|
|
symptomatic ruptured aneurysm
Patients with symptomatic ruptured aortic aneurysms greater than 3 cm who received a clinical indicated CT
|
|
|
patients with small aneurysms
Patients with small aortic aneurysms approximately 5.5 cm, ruptured and not ruptured, who received a clinical indicated CT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To calculated the rupture risk equivalent diameter (RRED) of the aortic aneurysm and rupture risk-index in the intraluminal thrombus within the aortic aneurysm.
Time Frame: CT Data from 01/2004-12/2013
|
By using the finite analysis from the CT data the peak wall stress (PWS), the peak wall rupture (PWRR) and the mises stress within the aortic aneurysm depending on the diameter and volume of the aortic aneurysm and of the intraluminal thrombus will be measured.
|
CT Data from 01/2004-12/2013
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Anticipated)
December 1, 2016
Study Completion (Anticipated)
December 1, 2017
Study Registration Dates
First Submitted
June 8, 2016
First Submitted That Met QC Criteria
June 10, 2016
First Posted (Estimate)
June 15, 2016
Study Record Updates
Last Update Posted (Estimate)
June 15, 2016
Last Update Submitted That Met QC Criteria
June 10, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KEK-ZH-Nr. 2015-0156
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.